The Center for Molecular Imaging Research (CMIR) at Massachusetts General Hospital and Harvard Medical School is engaged in innovative research of molecular phenomena in diseases such as cancer, atheroscleorosis and inflammation. The long term goals of CMIR are the development of novel technologies for in vivo sensing and imaging of molecular events. In addition, the center works to develop these new tools into clinical applications that can save lives.
The unique strength of the CMIR lies in the combination of its advanced chemistry resources (to synthesize molecular imaging probes), its programmatic effort to discover and validate new targets for molecular imaging, and in its wide range of cutting-edge, dedicated imaging equipment.
CMIR also offers lecture series and numerous research opportunities for postdoctoral fellows, graduate students and visiting scholars.
Learn more by visiting thewebsite.
Researchers at Massachusetts General Hospital and Harvard University have demonstrated that a handheld device can be used to count as few as 20 bacteria in a sputum sample in a half hour.
Researchers affiliated with the Massachusetts General Hospital Department of Radiology have developed a simple, noninvasive way to detect early cancer by using new technology to look at a component in the blood.